Patent Assignment
Reel/Frame 065521/0109
Patent Security Agreement
Recorded: 2023-11-08
Pages: 6
Assignor
ADC THERAPEUTICS SA
Executed: 2023-11-03
Assignee
OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.
399 PARK AVENUE, 38TH FLOOR, NEW YORK, NEW YORK, 10022
Covered Property
(1)
Pyrrolobenzodiazepine-Anti-CD22 Antibody Conjugates
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 31, 2020
From: VAN BERKEL, PATRICIUS HENDRIKUS CORNELIS
To: A.T. DEVELOPMENT SWITZERLAND SÀRL
Reel/Frame 053649/0470 →
Assignment of Assignor's Interest
Aug 31, 2020
From: HOWARD, PHILIP WILSON
To: MEDIMMUNE LIMITED
Reel/Frame 053649/0515 →
Assignment of Assignor's Interest
Sep 3, 2020
From: A.T. DEVELOPMENT SWITZERLAND SÀRL
To: ADC THERAPEUTICS S.A.
Reel/Frame 053687/0645 →
Security Interest
Sep 7, 2022
From: ADC THERAPEUTICS SA
To: OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.
Reel/Frame 061387/0715 →
Patent Security Agreement
Dec 27, 2022
From: ADC THERAPEUTICS SA
To: OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.
Reel/Frame 062228/0763 →